Type 1 Interferon Signature Predicts Development of Rheumatoid Arthritis.

被引：0
|
作者：
Lubbers, Joyce [1 ]
Brink, Mikael [2 ]
van de Stadt, Lotte A. [3 ]
Vosslamber, Saskia [1 ]
Wesseling, John G. [1 ]
van Schaardenburg, Dirkjan [3 ]
Rantapaa-Dahlqvist, Solbritt M. [2 ]
Verweij, Cornelis L. [1 ]
机构：
[1] Vrije Univ Amsterdam Med Ctr, Amsterdam, Netherlands
[2] Umea Univ, Umea, Sweden
[3] Jan van Breemen Res Inst Reade, Amsterdam, Netherlands
来源：
ARTHRITIS AND RHEUMATISM | 2011年 / 63卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2178
引用
收藏
页码：S848 / S848
页数：1
相关论文
共 50 条
  • [41] The etiology of rheumatoid arthritis.
    Cecil, RL
    Nicholls, EE
    Stainsby, WJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 1931, 181 : 12 - 25
  • [42] Treatment of rheumatoid arthritis.
    Jones, RL
    BRITISH MEDICAL JOURNAL, 1902, 1902 : 1931 - 1931
  • [43] A CD4+T-Cell Gene Expression Signature Predicts Drug Survival On Methotrexate Monotherapy in Early Rheumatoid Arthritis.
    Pratt, Arthur G.
    Brown, Philip M.
    Cockell, Simon J.
    Wilson, Gillian
    Isaacs, John D.
    ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S335 - S335
  • [44] Higher Expression of Type 1 Interferon in Synovitis of Patient with Undifferentiated Arthritis before They Met Rheumatoid Arthritis Criteria Compared to Established Rheumatoid Arthritis. a Retrospective Study with 14 Years of Follow-up
    Cuervo, Andrea
    Celis, Raquel
    Ramirez, Julio
    Usategui, Alicia
    Fare, Regina
    Victoria Hernandez, M.
    Ruiz-Esquide, Virginia
    Inciarte-Mundo, Jose
    Sanmarti, Raimon
    Pablos, Jose L.
    Canete, Juan D.
    ARTHRITIS & RHEUMATOLOGY, 2017, 69
  • [45] THE INTERFERON TYPE I SIGNATURE TOWARDS PREDICTION OF NON-RESPONSE TO RITUXIMAB IN RHEUMATOID ARTHRITIS PATIENTS
    Raterman, Hennie G.
    Vosslamber, Saskia
    de Ridder, Sander
    de Jong, Tamrah
    Nurmohamed, Michael T.
    Lems, Willem F.
    Boers, Maarten
    van de Wiel, Mark
    Dijkmans, Ben A. C.
    Verweij, Cornelis L.
    Voskuyl, Alexandre E.
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 : A5 - A5
  • [46] The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
    Raterman, Hennie G.
    Vosslamber, Saskia
    de Ridder, Sander
    Nurmohamed, Michael T.
    Lems, Willem F.
    Boers, Maarten
    van de Wiel, Mark
    Dijkmans, Ben A. C.
    Verweij, Cornelis L.
    Voskuyl, Alexandre E.
    ARTHRITIS RESEARCH & THERAPY, 2012, 14 (02)
  • [47] Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis
    Brian J Schmidt
    Fergal P Casey
    Thomas Paterson
    Jason R Chan
    BMC Bioinformatics, 14
  • [48] Alternate virtual populations elucidate the type I interferon signature predictive of the response to rituximab in rheumatoid arthritis
    Schmidt, Brian J.
    Casey, Fergal P.
    Paterson, Thomas
    Chan, Jason R.
    BMC BIOINFORMATICS, 2013, 14
  • [49] Heterogeneity of the Type I Interferon Signature in Rheumatoid Arthritis: A Potential Limitation for Its Use As a Clinical Biomarker
    Rodriguez-Carrio, Javier
    Alperi-Lopez, Mercedes
    Lopez, Patricia
    Ballina-Garcia, Francisco J.
    Suarez, Ana
    FRONTIERS IN IMMUNOLOGY, 2018, 8
  • [50] The interferon type I signature towards prediction of non-response to rituximab in rheumatoid arthritis patients
    Hennie G Raterman
    Saskia Vosslamber
    Sander de Ridder
    Michael T Nurmohamed
    Willem F Lems
    Maarten Boers
    Mark van de Wiel
    Ben AC Dijkmans
    Cornelis L Verweij
    Alexandre E Voskuyl
    Arthritis Research & Therapy, 14
12345